Jiaxuan Wu

Title: Jiaxuan Wu: Innovator in Drug Synthesis

Introduction

Jiaxuan Wu is a notable inventor based in Jiaxing, China. He has made significant contributions to the field of drug synthesis, particularly through his innovative methods in preparing pharmaceutical intermediates. His work is characterized by a focus on improving the efficiency and quality of drug synthesis processes.

Latest Patents

Jiaxuan Wu holds a patent for a method titled "Method for preparation of trans-n-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone as intermediate of halofuginone." This patent describes a novel approach to synthesizing trans-N-benzyloxycarbonyl-(3-hydroxy-2-piperidinyl)-2-propanone, which is crucial for the production of halofuginone. The method utilizes amino-substituted pentanal and a thiazolyl sulfoxide compound as raw materials, employing Mislow-Evans rearrangement reaction and subsequent Lewis acid catalysis. This innovative technique achieves high yields and stable qualities, providing a new reference route for synthesis while avoiding the use of expensive metal catalysts.

Career Highlights

Jiaxuan Wu is currently associated with Chengda Pharmaceuticals Co., Ltd., where he continues to advance his research in drug synthesis. His work has garnered attention for its practical applications in the pharmaceutical industry, contributing to the development of more efficient drug manufacturing processes.

Collaborations

Jiaxuan Wu collaborates with esteemed colleagues, including Yu Feng and Hong Xu. Their combined expertise enhances the research and development efforts at Chengda Pharmaceuticals, fostering an environment of innovation and discovery.

Conclusion

Jiaxuan Wu's contributions to drug synthesis exemplify the impact of innovative thinking in the pharmaceutical field. His patented methods not only improve the efficiency of drug production but also pave the way for future advancements in pharmaceutical chemistry.